People · Operator

Henry J. Kay

Named in public records as an officer, director or promoter · active 2024–2025 · Pharmaceuticals

1
Companies
2
Filings
$31.6M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Cristcot LLCPharmaceuticalsSeries A$31.6M$37.4M2024
Operator network

Henry J. Kay at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Ernest H. Pomerantz · 4 companies · 1 sharedErnest H. Pomeran…David S. Shepherd · 2 companies · 1 sharedDavid S. ShepherdJohn S. Davagian II · 2 companies · 1 sharedJohn S. Davagian …Mark C. Ensign · 2 companies · 1 sharedMark C. EnsignDavid H. Shepard · 1 companies · 1 sharedDavid H. ShepardDavid H. Shepherd · 1 companies · 1 sharedDavid H. ShepherdHenry H. Kay · 1 companies · 1 sharedHenry H. KayJames C. Bartlett · 1 companies · 1 sharedJames C. BartlettJames H. Bartlett · 1 companies · 1 sharedJames H. BartlettJennifer J. Davagian · 1 companies · 1 sharedJennifer J. Davag…John H. Davagian · 1 companies · 1 sharedJohn H. DavagianJohn S. Davagian · 1 companies · 1 sharedJohn S. DavagianMarc S. Keller · 1 companies · 1 sharedMarc S. KellerRichard H. Warburg · 1 companies · 1 sharedRichard H. WarburgRichard S. Warburg · 1 companies · 1 sharedRichard S. WarburgCristcot LLC · $31.6M raisedCristcot LLCHenry J. KayHK
Henry J. Kay Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Henry J. Kay on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Ernest H. Pomerantz14
John S. Davagian II12
Mark C. Ensign12
David S. Shepherd12
John S. Davagian11
James H. Bartlett11
John H. Davagian11
David H. Shepard11
Henry H. Kay11
James C. Bartlett11
Marc S. Keller11
Richard S. Warburg11
Richard H. Warburg11
Jennifer J. Davagian11
David H. Shepherd11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.